Ongoing selection for a uniquely human null allele of SIGLEC12 in world‐wide populations may protect against the risk of advanced carcinomas

por Siddiqui, Shoib S., Vaill, Michael, Varki, Ajit
Publicado 2021

Human‐specific polymorphic pseudogenization of SIGLEC12 protects against advanced cancer progression

por Siddiqui, Shoib S, Vaill, Michael, Do, Raymond, Khan, Naazneen, Verhagen, Andrea L, Zhang, Wu, Lenz, Heinz‐Josef, Johnson‐Pais, Teresa L, Leach, Robin J, Fraser, Gary, Wang, Charles, Feng, Gen‐Sheng, Varki, Nissi, Varki, Ajit
Publicado 2020